| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 120.03B | 112.43B | 100.41B | 84.69B | 82.26B | 72.99B |
| Gross Profit | 22.75B | 20.64B | 20.17B | 18.85B | 19.74B | 17.11B |
| EBITDA | 11.60B | 9.85B | 9.79B | 8.62B | 9.50B | 7.73B |
| Net Income | 7.70B | 6.48B | 6.45B | 5.62B | 6.34B | 4.98B |
Balance Sheet | ||||||
| Total Assets | 107.00B | 105.48B | 95.28B | 88.94B | 82.66B | 84.38B |
| Cash, Cash Equivalents and Short-Term Investments | 28.38B | 24.47B | 34.60B | 32.25B | 35.59B | 23.14B |
| Total Debt | 20.94B | 18.23B | 12.75B | 12.10B | 12.64B | 20.82B |
| Total Liabilities | 33.00B | 32.55B | 27.25B | 25.92B | 23.74B | 30.51B |
| Stockholders Equity | 74.00B | 72.92B | 68.03B | 63.02B | 58.92B | 53.87B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -13.98B | 4.62B | -4.57B | 22.12B | 7.87B |
| Operating Cash Flow | 0.00 | -13.88B | 4.67B | -4.53B | 22.21B | 8.07B |
| Investing Cash Flow | 0.00 | 4.91B | -5.04B | 1.93B | 7.00M | -89.00M |
| Financing Cash Flow | 0.00 | 3.84B | -2.29B | -738.00M | -9.68B | -6.78B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥54.13B | 8.51 | ― | 3.64% | 15.82% | 22.32% | |
74 Outperform | ¥104.76B | 5.88 | ― | 2.93% | 20.83% | 57.13% | |
73 Outperform | ¥130.22B | 20.19 | 15.81% | 2.93% | 84.20% | 137.87% | |
71 Outperform | ¥91.63B | 14.58 | ― | 2.19% | 4.72% | 47.55% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
64 Neutral | ¥44.06B | 9.84 | ― | 0.45% | -8.33% | -36.89% | |
62 Neutral | ¥69.78B | 8.53 | ― | 2.89% | -3.09% | -35.66% |